The case for & against
Bull & Bear analysis
Bullish
Tenet Healthcare Corporation (NYSE: THC) is a leading provider in the healthcare services sector, operating hospitals, outpatient centers, and surgical facilities across the United States. The company focuses on high-acuity care, emphasizing specialized surgical services and operational efficiencies. Tenet's extensive healthcare network is strategically designed to cater to the evolving demands of the market while navigating an increasingly complex regulatory environment, including payer dynamics and insurance enrollment fluctuations.
Bull says
- ↑2025 adjusted EBITDA $4.57B (+14% YoY; +210 bps margin)
- ↑Free cash flow $2.53B in 2025; 2026 FCF guide $1.495–1.695B; $2.97B cash
- ↑$350M earmarked for M&A in 2025 to expand specialized facilities
- ↑Double-digit same-store volume growth in high-acuity joint replacements
- ↑16 of 17 analysts rate Strong Buy; avg price target up to $308
- ↑Strong profitability and earnings yield; positive momentum; high 13F ownership
Bear says
- ↓Negative book-to-price and dividend yield scores indicate overvaluation and weak capital return
- ↓Potential 20% decline in exchange patient enrollment as premium tax credits expire
- ↓Heavy reliance on Medicaid supplemental payments risks subsidy expirations
- ↓Rising labor costs amid inflation may compress margins
- ↓High leverage elevates interest-rate risk; elevated short interest hints at skepticism
- ↓Variant perception suggests historical margins may not sustain under current pressures
Investment themes with THC
Buybacks↓ -0.29%
Companies repurchasing their own shares
C · JCI · WFC
Health Care Providers↓ -0.37%
UNH · CVS · HCA
Earnings Call · Q2 2025 · Mgmt. Guidance
Updated 08-22-2026bullish
Transcript signals
Bull points
- our strength in cardiovascular, orthopedic, spine, neurosurgery, broad-based general surgery, robotics continues to focus on in terms of our work.
- we obviously have very strong free cash flow performance, have increased our guidance for free cash flow after NCI, you know, up $195 million.
- our capital allocation priorities haven't changed, right? USPI, M&A, hospital capex or high acuity strategy, and then maintaining our deleveraged balance sheet and a balance share purchase approach.
Bear points
- we really don't have any insight into how this will be implemented. There are new legislative proposals that have already come up attempting to rescind some parts of the OBBB, which are in play in Congress.
- deceleration there in both the inpatient and adjusted admissions in the quarter. You took down the guidance by, I think, 50 basis points.
Read full transcript analysis ›